Screener
Amphastar Pharmaceuticals AMPH Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's net margin?
- Amphastar Pharmaceuticals (AMPH) reported net margin of 10.8% in Q2 2026.
- How has Amphastar Pharmaceuticals's net margin changed year-over-year?
- Amphastar Pharmaceuticals's net margin decreased by 42.3% year-over-year, from 18.6% to 10.8%.
- What is the long-term trend for Amphastar Pharmaceuticals's net margin?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's net margin has grown at a -1.0% compound annual growth rate (CAGR), from 14.2% to 13.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Amphastar Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude